Shuyu Liu

Registered Foreign Lawyer (New York)

香港 + 852.2526.6895

联系：

Share

Shuyu Liu advises clients on a wide range of complex cross-border transactions, including several notable market-leading deals. She focuses on U.S. and Hong Kong IPOs (initial public offerings) as well as private and public M&A transactions.

Shuyu has experience working with companies in the technology, media and telecoms, consumer products, health care, and luxury items business sectors. She works with premier financial institutions clients as well as prestigious public and private companies in the Asia-Pacific (APAC) region.

Shuyu's representative deals prior to joining Jones Day in 2025 include the U.S. IPO of Didi Global, the Hong Kong IPO of Pop Mart International Group, and the privatization of New Frontier Health Corporation (operator of Hemujia) and the de-SPAC (Special Purpose Acquisition Company) of Primavera Capital Acquisition Corporation and its business combination with Lanvin Group.

经验

  • China International Capital Corporation Hong Kong Securities Limited completes IPO by MeiG Smart Technology Co., Ltd.Jones Day advised China International Capital Corporation Hong Kong Securities Limited, as sponsor, in connection with the initial public offering and listing by MeiG Smart Technology Co., Ltd. ("MeiG Smart"; stock code: 002881.SZ, 3268.HK) on the Hong Kong Stock Exchange on March 10, 2026.
  • OmniVision Integrated Circuits Group, Inc. completes $616 million IPO on The Stock Exchange of Hong Kong LimitedJones Day acted as Hong Kong and U.S. counsel for OmniVision Integrated Circuits Group, Inc. (“OmniVision”) in connection with its approximately US$616 million initial public offering on The Stock Exchange of Hong Kong Limited (excluding the exercise of the green shoe).
    • 查看全部经验

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice